Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 58 is a noncoding RNA pseudogene related to the parent gene RN7SK, which is part of the 7SK small nuclear ribonucleoprotein complex involved in transcriptional regulation via RNA polymerase II pausing[2]. However, pseudogenes such as RN7SKP58 do not encode functional proteins and are not validated as molecular targets, receptors, enzymes, or biomarkers for drug therapy. No disease associations, drug interactions, or mechanisms of action have been established for RN7SKP58. The description and canonical information provided in various databases, including GeneCards, confirm its status as a pseudogene rather than a therapeutic target[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 58 (RN7SKP58).